China has developed advances in immune cell therapies, but there is relatively little information on stem cell based therapies. In this webinar, we bring together 2 researchers who have spent 10 years developing stem cell research, bioprocessing and machine learning skills in Singapore and have since started their own company and research teams in China. Prof. Zhang Zhiyong, Founder and CEO of REGEN-αGEEK (Haining) Biotechnology Co., Ltd. and Prof. Yin Lu from Nanchang University will be speakers.
Key Learning Objectives: Understand the bioprocessing challenges in cell therapy manufacturing in China and the solutions provided.
Understand how machine learning is helping to guide stem cell therapy for osteoarthritis.
Discuss collaborations and engaging Chinese researchers with ISCT.
